How much revenue did BIO-Key International generate this year?
BIO-Key International has achieved a revenue of 7.91 M USD this year.
BIO-Key International Revenue 2024
BIO-Key International Revenue
7.91 M USD
Ticker
BKYI
ISIN
US09060C4087
WKN
A2QJDQ
In 2024, BIO-Key International's sales reached 7.91 M USD, a 1.96% difference from the 7.75 M USD sales recorded in the previous year.
The BIO-Key International Revenue history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) |
|---|---|---|
| 2025e | 8.67 | 16,51 |
| 2024e | 7.91 | 18,10 |
| 2023 | 7.75 | 18,46 |
| 2022 | 7.02 | 65,24 |
| 2021 | 5.11 | 67,32 |
| 2020 | 2.84 | 71,83 |
| 2019 | 2.27 | -8,37 |
| 2018 | 4.04 | -2,97 |
| 2017 | 6.3 | 48,57 |
| 2016 | 2.98 | 75,50 |
| 2015 | 5.26 | 75,67 |
| 2014 | 4.01 | 81,30 |
| 2013 | 1.99 | 80,40 |
| 2012 | 3.84 | 84,90 |
| 2011 | 3.51 | 76,92 |
| 2010 | 3.52 | 84,09 |
| 2009 | 2.36 | 78,39 |
| 2008 | 3.38 | 90,24 |
| 2007 | 9.99 | 82,18 |
| 2006 | 11.29 | 74,93 |
| 2005 | 14.23 | 72,94 |
| 2004 | 5.72 | 63,99 |
BIO-Key International Revenue, EBIT, Net Income US09060C4087 · A2QJDQ
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into BIO-Key International, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by BIO-Key International from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects BIO-Key International’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of BIO-Key International. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into BIO-Key International’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing BIO-Key International’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on BIO-Key International’s growth potential.
BIO-Key International Revenue, EBIT and net profit per share
| Date | BIO-Key International Revenue | BIO-Key International EBIT | BIO-Key International Net Income |
|---|---|---|---|
| 2025e | 8.67 M undefined | -2.92 M undefined | -4.79 M undefined |
| 2024e | 7.91 M undefined | -3.11 M undefined | -5.71 M undefined |
| 2023 | 7.75 M undefined | -8.83 M undefined | -8.52 M undefined |
| 2022 | 7.02 M undefined | -8.03 M undefined | -11.91 M undefined |
| 2021 | 5.11 M undefined | -4.94 M undefined | -5.07 M undefined |
| 2020 | 2.84 M undefined | -5.2 M undefined | -9.79 M undefined |
| 2019 | 2.27 M undefined | -6.56 M undefined | -14.59 M undefined |
| 2018 | 4.04 M undefined | -6.87 M undefined | -8.5 M undefined |
| 2017 | 6.3 M undefined | -4.28 M undefined | -5.04 M undefined |
| 2016 | 2.98 M undefined | -4.2 M undefined | -4.99 M undefined |
| 2015 | 5.26 M undefined | -1.7 M undefined | -1.99 M undefined |
| 2014 | 4.01 M undefined | -2.04 M undefined | -1.88 M undefined |
| 2013 | 1.99 M undefined | -2.52 M undefined | -2.58 M undefined |
| 2012 | 3.84 M undefined | 30,000 undefined | 0 undefined |
| 2011 | 3.51 M undefined | -1.45 M undefined | -1.9 M undefined |
| 2010 | 3.52 M undefined | -1.2 M undefined | -950,000 undefined |
| 2009 | 2.36 M undefined | -2.46 M undefined | 4.17 M undefined |
| 2008 | 3.38 M undefined | -1.69 M undefined | -1.77 M undefined |
| 2007 | 9.99 M undefined | -5.37 M undefined | -2.95 M undefined |
| 2006 | 11.29 M undefined | -6.67 M undefined | -12.12 M undefined |
| 2005 | 14.23 M undefined | -8.29 M undefined | -3.99 M undefined |
| 2004 | 5.72 M undefined | -6.44 M undefined | -11.23 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2004 | 5.72 M USD | -6.44 M USD | -11.23 M USD |
| 2005 | 14.23 M USD | -8.29 M USD | -3.99 M USD |
| 2006 | 11.29 M USD | -6.67 M USD | -12.12 M USD |
| 2007 | 9.99 M USD | -5.37 M USD | -2.95 M USD |
| 2008 | 3.38 M USD | -1.69 M USD | -1.77 M USD |
| 2009 | 2.36 M USD | -2.46 M USD | 4.17 M USD |
| 2010 | 3.52 M USD | -1.2 M USD | -950,000 USD |
| 2011 | 3.51 M USD | -1.45 M USD | -1.9 M USD |
| 2012 | 3.84 M USD | 30,000 USD | 0 USD |
| 2013 | 1.99 M USD | -2.52 M USD | -2.58 M USD |
| 2014 | 4.01 M USD | -2.04 M USD | -1.88 M USD |
| 2015 | 5.26 M USD | -1.7 M USD | -1.99 M USD |
| 2016 | 2.98 M USD | -4.2 M USD | -4.99 M USD |
| 2017 | 6.3 M USD | -4.28 M USD | -5.04 M USD |
| 2018 | 4.04 M USD | -6.87 M USD | -8.5 M USD |
| 2019 | 2.27 M USD | -6.56 M USD | -14.59 M USD |
| 2020 | 2.84 M USD | -5.2 M USD | -9.79 M USD |
| 2021 | 5.11 M USD | -4.94 M USD | -5.07 M USD |
| 2022 | 7.02 M USD | -8.03 M USD | -11.91 M USD |
| 2023 | 7.75 M USD | -8.83 M USD | -8.52 M USD |
| 2024e | 7.91 M USD | -3.11 M USD | -5.71 M USD |
| 2025e | 8.67 M USD | -2.92 M USD | -4.79 M USD |
BIO-Key International stock margins US09060C4087 · A2QJDQ
The BIO-Key International margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BIO-Key International. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BIO-Key International.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the BIO-Key International's sales revenue. A higher gross margin percentage indicates that the BIO-Key International retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the BIO-Key International's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the BIO-Key International's total revenue generated. When comparing the revenue margin year over year, investors can gauge the BIO-Key International's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the BIO-Key International. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the BIO-Key International's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
BIO-Key International Margin History
| BIO-Key International Gross margin | BIO-Key International Profit margin | BIO-Key International EBIT margin | BIO-Key International Profit margin |
|---|---|---|---|
| 2025e | 18.46 % | -33.65 % | -55.24 % |
| 2024e | 18.46 % | -39.34 % | -72.22 % |
| 2023 | 18.46 % | -113.82 % | -109.89 % |
| 2022 | 65.24 % | -114.39 % | -169.66 % |
| 2021 | 67.32 % | -96.67 % | -99.22 % |
| 2020 | 71.83 % | -183.1 % | -344.72 % |
| 2019 | -8.37 % | -288.99 % | -642.73 % |
| 2018 | -2.97 % | -170.05 % | -210.4 % |
| 2017 | 48.57 % | -67.94 % | -80 % |
| 2016 | 75.5 % | -140.94 % | -167.45 % |
| 2015 | 75.67 % | -32.32 % | -37.83 % |
| 2014 | 81.3 % | -50.87 % | -46.88 % |
| 2013 | 80.4 % | -126.63 % | -129.65 % |
| 2012 | 84.9 % | 0.78 % | 0 % |
| 2011 | 76.92 % | -41.31 % | -54.13 % |
| 2010 | 84.09 % | -34.09 % | -26.99 % |
| 2009 | 78.39 % | -104.24 % | 176.69 % |
| 2008 | 90.24 % | -50 % | -52.37 % |
| 2007 | 82.18 % | -53.75 % | -29.53 % |
| 2006 | 74.93 % | -59.08 % | -107.35 % |
| 2005 | 72.94 % | -58.26 % | -28.04 % |
| 2004 | 63.99 % | -112.59 % | -196.33 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2004 | 63.99 % | -112.59 % | -196.33 % |
| 2005 | 72.94 % | -58.26 % | -28.04 % |
| 2006 | 74.93 % | -59.08 % | -107.35 % |
| 2007 | 82.18 % | -53.75 % | -29.53 % |
| 2008 | 90.24 % | -50 % | -52.37 % |
| 2009 | 78.39 % | -104.24 % | 176.69 % |
| 2010 | 84.09 % | -34.09 % | -26.99 % |
| 2011 | 76.92 % | -41.31 % | -54.13 % |
| 2012 | 84.9 % | 0.78 % | 0 % |
| 2013 | 80.4 % | -126.63 % | -129.65 % |
| 2014 | 81.3 % | -50.87 % | -46.88 % |
| 2015 | 75.67 % | -32.32 % | -37.83 % |
| 2016 | 75.5 % | -140.94 % | -167.45 % |
| 2017 | 48.57 % | -67.94 % | -80 % |
| 2018 | -2.97 % | -170.05 % | -210.4 % |
| 2019 | -8.37 % | -288.99 % | -642.73 % |
| 2020 | 71.83 % | -183.1 % | -344.72 % |
| 2021 | 67.32 % | -96.67 % | -99.22 % |
| 2022 | 65.24 % | -114.39 % | -169.66 % |
| 2023 | 18.46 % | -113.82 % | -109.89 % |
| 2024e | 18.46 % | -39.34 % | -72.22 % |
| 2025e | 18.46 % | -33.65 % | -55.24 % |
BIO-Key International Aktienanalyse
What does BIO-Key International do?
BIO-Key International Inc. is a company specializing in biometric authentication and security solutions. It was founded in 1993 as a biometric research laboratory and has since become a leading provider of biometric authentication and security solutions worldwide. The company's business model consists of developing and selling biometric authentication and security solutions. It offers a wide range of products for various industries and customers, including businesses, government agencies, and the military. Some of its products include fingerprint-based authentication, facial recognition, iris scanner technologies, and software solutions such as ID Director. BIO-Key has expanded its offerings to include biometric-based hardware products such as fingerprint scanners for kiosks and ATMs, as well as biometric access control systems for offices and buildings. The company also specializes in Identity and Access Management (IAM) solutions. It is headquartered in Wall, New Jersey, operates offices in Europe and other continents, and is listed on the American stock exchange. Due to its technical capabilities, innovation, and market-oriented approach, BIO-Key is well-positioned to continue playing a leading role in the field of biometric authentication and security solutions in the future. BIO-Key International ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding BIO-Key International's Sales Figures
The sales figures of BIO-Key International originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing BIO-Key International’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize BIO-Key International's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in BIO-Key International’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about BIO-Key International stock
How much was the turnover of the company BIO-Key International compared to the previous year?
The revenue of BIO-Key International has increased by 1.96% increased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of BIO-Key International?
The revenue of BIO-Key International is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of BIO-Key International measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of BIO-Key International so important for investors?
The revenue of BIO-Key International is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does BIO-Key International pay?
Over the past 12 months, BIO-Key International paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BIO-Key International is expected to pay a dividend of 0 USD.
What is the dividend yield of BIO-Key International?
The current dividend yield of BIO-Key International is .
When does BIO-Key International pay dividends?
BIO-Key International pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of BIO-Key International?
BIO-Key International paid dividends every year for the past 0 years.
What is the dividend of BIO-Key International?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is BIO-Key International located?
BIO-Key International is assigned to the 'Information technology' sector.
Wann musste ich die Aktien von BIO-Key International kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BIO-Key International from 12/12/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/12/2024.
When did BIO-Key International pay the last dividend?
The last dividend was paid out on 12/12/2024.
What was the dividend of BIO-Key International in the year 2023?
In the year 2023, BIO-Key International distributed 0 USD as dividends.
In which currency does BIO-Key International pay out the dividend?
The dividends of BIO-Key International are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BIO-Key International
Our stock analysis for BIO-Key International Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BIO-Key International Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
- BIO-Key International Revenue
- BIO-Key International Net Income
- BIO-Key International P/E
- BIO-Key International P/S
- BIO-Key International EBIT
- BIO-Key International Dividend
- BIO-Key International Stocks
- BIO-Key International Market capitalization
- BIO-Key International Debt
- BIO-Key International Liabilities
- BIO-Key International Equity
- BIO-Key International AAQS
- BIO-Key International Employees
- BIO-Key International ROE
- BIO-Key International ROA
- BIO-Key International ROCE
